Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 1475 entries
View as:

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06951698 Org: User:
Start: 06/11/25 End: 11/01/26 Due: 11/01/27

Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

Phase: N/A Priority: Normal
NCT ID: NCT02339818 Org: User:
Start: 08/31/15 End: 02/28/17 Due: 02/28/18

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00420199 Org: User:
Start: 05/31/07 End: 05/31/10 Due: 05/31/11

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02305563 Org: User:
Start: 01/27/15 End: 06/04/19 Due: 06/04/20

Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01024062 Org: User:
Start: 12/31/02 End: 03/31/05 Due: 03/31/06

Expanded Access for Abatacept

Phase: N/A Priority: Normal
NCT ID: NCT05170672 Org: User:
Start: - End: - Due: -

Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04249284 Org: User:
Start: 02/06/20 End: 03/15/20 Due: 03/15/21

Belatacept in Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00555321 Org: User:
Start: 01/31/08 End: 06/30/11 Due: 06/30/12

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

Phase: N/A Priority: Normal
NCT ID: NCT07008820 Org: User:
Start: 05/13/25 End: 10/31/25 Due: 10/31/26

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

Phase: N/A Priority: Normal
NCT ID: NCT01438424 Org: User:
Start: 01/31/01 End: 04/30/11 Due: 04/30/12

A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05134948 Org: User:
Start: 11/30/21 End: 10/22/25 Due: 10/22/26

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Phase: N/A Priority: Normal
NCT ID: NCT02971683 Org: User:
Start: 05/04/17 End: 08/02/22 Due: 08/02/23

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT02037737 Org: User:
Start: 09/30/16 End: 01/31/18 Due: 01/31/19

Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01386359 Org: User:
Start: 02/29/12 End: 04/30/19 Due: 04/30/20

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01860976 Org: User:
Start: 06/17/13 End: 06/30/20 Due: 06/30/21

A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT03198013 Org: User:
Start: 11/11/08 End: 05/18/09 Due: 05/18/10

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Phase: N/A Priority: Normal
NCT ID: NCT00971308 Org: User:
Start: 10/31/09 End: 08/31/10 Due: 08/31/11

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Phase: N/A Priority: Normal
NCT ID: NCT06929273 Org: User:
Start: 07/22/25 End: 06/13/28 Due: 06/13/29

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

Phase: N/A Priority: Normal
NCT ID: NCT05421442 Org: User:
Start: 06/13/19 End: 01/30/26 Due: 01/30/27

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

Phase: N/A Priority: Normal
NCT ID: NCT05949684 Org: User:
Start: 10/24/23 End: 03/11/30 Due: 03/11/31

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Phase: N/A Priority: Normal
NCT ID: NCT06926868 Org: User:
Start: 07/15/25 End: 05/15/30 Due: 05/15/31

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Phase: N/A Priority: Normal
NCT ID: NCT06937229 Org: User:
Start: 11/21/25 End: 07/20/29 Due: 07/20/30

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT04540705 Org: User:
Start: 09/11/20 End: 01/18/24 Due: 01/18/25

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01447394 Org: User:
Start: 03/31/12 End: 08/31/14 Due: 08/31/15

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Phase: N/A Priority: Normal
NCT ID: NCT06448793 Org: User:
Start: 03/01/25 End: 04/30/25 Due: 04/30/26